carnitine has been researched along with Osteoporosis in 10 studies
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was carried out to assess the protective bone-sparing effect of carnitine with anti-inflammatory properties on chronic inflammation-induced bone loss in ovariectomised (OVX) rats." | 7.79 | The role of carnitine on ovariectomy and inflammation-induced osteoporosis in rats. ( Ayan, AK; Aydin, A; Bayir, Y; Bilen, H; Cadirci, E; Ferah, I; Halici, Z; Orsal, E; Ozaltin, S; Ozkanlar, S; Seven, B, 2013) |
| "The aim of our work was to test the influence of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients in a randomized study." | 7.74 | Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients. ( Cibulka, R; Pikner, R; Racek, J; Rajdl, D; Siroka, R; Studenovska, M; Trefil, L; Vesela, E, 2007) |
| "By experiments on cells (neurons, hepatocytes, and fibroblasts) that are targets for thyroid hormones and a randomized clinical trial on iatrogenic hyperthyroidism, we validated the concept that L-carnitine is a peripheral antagonist of thyroid hormone action." | 6.21 | Effects of carnitine on thyroid hormone action. ( Amato, A; Benvenga, S; Calvani, M; Trimarchi, F, 2004) |
| "Our data suggest three possible clinically actionable endotypes in primary OA: muscle weakness, arginine deficit and low inflammatory OA." | 4.02 | Endotypes of primary osteoarthritis identified by plasma metabolomics analysis. ( Furey, A; Liu, M; Rahman, P; Randell, EW; Sun, G; Werdyani, S; Zhai, G; Zhang, H, 2021) |
| "The aim of this study was to examine the effects of carnitine on bone healing in ovariectomy (OVX) and inflammation (INF)-induced osteoporotic rats." | 3.81 | Treatment with Carnitine Enhances Bone Fracture Healing under Osteoporotic and/or Inflammatory Conditions. ( Aksakal, AM; Albayrak, A; Ayan, AK; Aydin, A; Bayir, Y; Cadirci, E; Halici, Z; Karakus, E; Polat, B; Yildirim, OS, 2015) |
| "This study was carried out to assess the protective bone-sparing effect of carnitine with anti-inflammatory properties on chronic inflammation-induced bone loss in ovariectomised (OVX) rats." | 3.79 | The role of carnitine on ovariectomy and inflammation-induced osteoporosis in rats. ( Ayan, AK; Aydin, A; Bayir, Y; Bilen, H; Cadirci, E; Ferah, I; Halici, Z; Orsal, E; Ozaltin, S; Ozkanlar, S; Seven, B, 2013) |
| " The purpose of this study was to determine whether dietary supplementation of l-carnitine can influence bone density and slow the rate of bone turnover in an aging ovariectomized rat model." | 3.74 | Dietary l-carnitine supplementation improves bone mineral density by suppressing bone turnover in aged ovariectomized rats. ( Arjmandi, BH; Balakrishnan, A; Clark, RM; Hooshmand, S; Koo, SI; Owen, KQ, 2008) |
| "The aim of our work was to test the influence of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients in a randomized study." | 3.74 | Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients. ( Cibulka, R; Pikner, R; Racek, J; Rajdl, D; Siroka, R; Studenovska, M; Trefil, L; Vesela, E, 2007) |
| "Osteoporosis is a frequent disease among the elderly especially in postmenopausal women." | 1.48 | UPLC/Q-TOF-MS-based metabolomics study of the anti-osteoporosis effects of Achyranthes bidentata polysaccharides in ovariectomized rats. ( Wan, JB; Wang, C; Wang, Y; Yan, C; Zhang, D; Zhang, M; Zhang, Q, 2018) |
| "Treatment with atorvastatin+L-carnitine restored BMD, BMC, and bone strength to near normal levels." | 1.43 | L-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats. ( Murad, HA, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, SA | 1 |
| Abd El Reheem, MH | 1 |
| Elbahy, DA | 1 |
| Werdyani, S | 1 |
| Liu, M | 1 |
| Zhang, H | 1 |
| Sun, G | 1 |
| Furey, A | 1 |
| Randell, EW | 1 |
| Rahman, P | 1 |
| Zhai, G | 1 |
| Zhang, M | 1 |
| Wang, Y | 1 |
| Zhang, Q | 1 |
| Wang, C | 1 |
| Zhang, D | 1 |
| Wan, JB | 1 |
| Yan, C | 1 |
| Orsal, E | 1 |
| Halici, Z | 2 |
| Bayir, Y | 2 |
| Cadirci, E | 2 |
| Bilen, H | 1 |
| Ferah, I | 1 |
| Aydin, A | 2 |
| Ozkanlar, S | 1 |
| Ayan, AK | 2 |
| Seven, B | 1 |
| Ozaltin, S | 1 |
| Albayrak, A | 1 |
| Polat, B | 1 |
| Karakus, E | 1 |
| Yildirim, OS | 1 |
| Aksakal, AM | 1 |
| Murad, HA | 1 |
| Hooshmand, S | 1 |
| Balakrishnan, A | 1 |
| Clark, RM | 1 |
| Owen, KQ | 1 |
| Koo, SI | 1 |
| Arjmandi, BH | 1 |
| Benvenga, S | 1 |
| Amato, A | 1 |
| Calvani, M | 1 |
| Trimarchi, F | 1 |
| Cibulka, R | 1 |
| Racek, J | 1 |
| Pikner, R | 1 |
| Rajdl, D | 1 |
| Trefil, L | 1 |
| Vesela, E | 1 |
| Studenovska, M | 1 |
| Siroka, R | 1 |
| Patano, N | 1 |
| Mancini, L | 1 |
| Settanni, MP | 1 |
| Strippoli, M | 1 |
| Brunetti, G | 1 |
| Greco, G | 1 |
| Tamma, R | 1 |
| Vergari, R | 1 |
| Sardelli, F | 1 |
| Koverech, A | 1 |
| Colucci, S | 1 |
| Zallone, A | 1 |
| Grano, M | 1 |
1 review available for carnitine and Osteoporosis
| Article | Year |
|---|---|
Effects of carnitine on thyroid hormone action.
Topics: Bone Density; Carnitine; Female; Humans; Hyperthyroidism; Osteoporosis; Randomized Controlled Trials | 2004 |
1 trial available for carnitine and Osteoporosis
| Article | Year |
|---|---|
Effects of carnitine on thyroid hormone action.
Topics: Bone Density; Carnitine; Female; Humans; Hyperthyroidism; Osteoporosis; Randomized Controlled Trials | 2004 |
9 other studies available for carnitine and Osteoporosis
| Article | Year |
|---|---|
l-Carnitine ameliorates the osteoporotic changes and protects against simvastatin induced myotoxicity and hepatotoxicity in glucocorticoid-induced osteoporosis in rats.
Topics: Animals; Carnitine; Chemical and Drug Induced Liver Injury; Glucocorticoids; Myotoxicity; Osteoporos | 2022 |
Endotypes of primary osteoarthritis identified by plasma metabolomics analysis.
Topics: Aged; Arginine; Body Mass Index; Carnitine; Case-Control Studies; Coronary Disease; Diabetes Mellitu | 2021 |
UPLC/Q-TOF-MS-based metabolomics study of the anti-osteoporosis effects of Achyranthes bidentata polysaccharides in ovariectomized rats.
Topics: Achyranthes; Alitretinoin; Animals; Biomarkers; Carnitine; Docosahexaenoic Acids; Humans; Lysophosph | 2018 |
The role of carnitine on ovariectomy and inflammation-induced osteoporosis in rats.
Topics: Absorptiometry, Photon; Animals; Bone Density; Carnitine; Female; Inflammation; Interleukin-1; Inter | 2013 |
Treatment with Carnitine Enhances Bone Fracture Healing under Osteoporotic and/or Inflammatory Conditions.
Topics: Absorptiometry, Photon; Animals; Bone Density; Carnitine; Disease Models, Animal; Female; Fracture H | 2015 |
L-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats.
Topics: Animals; Atorvastatin; Bone Density; Bone Density Conservation Agents; Carnitine; Dose-Response Rela | 2016 |
Dietary l-carnitine supplementation improves bone mineral density by suppressing bone turnover in aged ovariectomized rats.
Topics: Acid Phosphatase; Aging; Alkaline Phosphatase; Animals; Bone Density; Carnitine; Collagen Type I; Di | 2008 |
Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients.
Topics: Aged; Bone and Bones; Bone Density; Calcium; Carnitine; Dietary Supplements; Female; Humans; Hyperpa | 2007 |
L: -carnitine fumarate and isovaleryl-L: -carnitine fumarate accelerate the recovery of bone volume/total volume ratio after experimetally induced osteoporosis in pregnant mice.
Topics: Animals; Calcification, Physiologic; Calcium; Calcium, Dietary; Carnitine; Cell Count; Cell Prolifer | 2008 |